• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ON-X LIFE TECHNOLOGIES, INC. ONX AORTIC CONFORM EXT 19; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ON-X LIFE TECHNOLOGIES, INC. ONX AORTIC CONFORM EXT 19; HEART-VALVE, MECHANICAL Back to Search Results
Model Number ONXACE-19
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Code Available (3191)
Event Date 10/02/2016
Event Type  Injury  
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Event Description
According to the implant registration card, patient received first valve onxace-19 on (b)(6) 2016 and required intervention explant on (b)(6) 2016 and subsequent replacement via another onxace-19 for yet unknown reasons.
 
Manufacturer Narrative
Cryolife field assurance received an e-mail 11/01/2016 from on-x device tracking, containing the implant registration cards (irc) for onxace-19 (on-x prosthetic aortic valve with conform-x sewing ring) valve, serial number (sn) (b)(4) implanted (b)(6) 2016 in the aortic position and onxace-19 valve sn (b)(4) implanted (b)(6) 2016 in the mitral position.The following additional information was requested from the surgeon's office by phone 11/09/2016: was this a reoperation or did the patient receive two implants, one for mitral and one for aortic as the ircs suggest, if the second surgery was a reoperation could the following be provided: indication (reason) for re-operation, what was the patient impact, current patient status, pertinent patient co-morbidities, are implant operative notes available?.An additional phone call was placed to the doctor¿s office 11/10/2016.A message was left requesting the above-referenced information.Further correspondence of facsimile transmission and two day federal express delivery were sent 11/09/2016.All attempts at correspondence were unmet.Based on all available information, there is no allegation of deficiency being made to either on-x valve.Therefore, complaint (b)(4) will be voided.
 
Event Description
According to the implant registration card, patient received first valve onxace-19 on (b)(6) 2016 and required intervention explant on (b)(6) 2016 and subsequent replacement via another onxace-19 for yet unknown reasons.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONX AORTIC CONFORM EXT 19
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ON-X LIFE TECHNOLOGIES, INC.
1300 e. anderson ln., bldg. b
austin TX 78752
Manufacturer (Section G)
ON-X LIFE TECHNOLOGIES, INC.
1300 e. anderson ln., bldg. b
austin TX 78752
Manufacturer Contact
rochelle maney
1655 roberts blvd
kennesaw, GA 30144
MDR Report Key6132359
MDR Text Key61033520
Report Number1649833-2016-00076
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/29/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberONXACE-19
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date11/01/2016
Date Manufacturer Received11/01/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age6 YR
-
-